Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Drug Abuse Initial Review Group, Medication Development Research Subcommittee.                    

*Date:*                         June 28, 2000.                    

*Time:*                         8 a.m. to 2 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Arlington Hyatt, 1325 Wilson Boulevard, Arlington, VA 22209.                    

*Contact Person:*                         Khursheed Asghar, PhD, Chief, Basic Sciences Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 3158, Msc 9547, Bethesda, MD 20892-9547, (301) 443-2620.                    

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Minority Institutions' Drug Abuse Research Development Program.                    

*Date:*                         June 28, 2000.                    

*Time:*                         3 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Arlington, 1325 Wilson Boulevard, Arlington, VA 22209.                    

*Contact Person:*                         Khursheed Asghar, PhD, Chief, Basic Sciences Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 3158, Msc 9547, Bethesda, MD 29089-2954, (301) 443-2620.                    

*Name of Committee:*                         National Institute on Drug Abuse Initial Review Group, Health Services Research Subcommittee.                    

*Date:*                         June 29-30, 2000.                              ( print page 33338)    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hotel Washington, 515 15th Street NW, Washington, DC 20004.                    

*Contact Person:*                         Marina L. Volkov, PhD, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1433.                    

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Medication Development Research.                    

*Date:*                         June 29, 2000.                    

*Time:*                         9 a.m. to 11 a.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Arlington, 1325 Wilson Blvd., Arlington, VA 22209.                    

*Contact Person:*                         Mark Swieter, PhD, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1389.                    

*Name of Committee:*                         National Institute on Drug Abuse Initial Review Group, Treatment Research Subcommittee.                    

*Date:*                         June 29-30, 2000.                    

*Time:*                         11 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hotel Washington, 515 15th Street, NW, Washington, DC 20004.                    

*Contact Person:*                         Kesinee Nimit, MD, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1432.                    

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Centers Review Committee.                    

*Date:*                         June 29, 2000.                    

*Time:*                         6 p.m. to 7:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes Street, Arlington, VA 22202.                    

*Contact Person:*                         Rita Liu, PhD, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.                    

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Aids Research Core Grants.                    

*Date:*                         June 30, 2000.                    

*Time:*                         8:30 a.m. to 5:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes Street, Arlington, VA 22202.                    

*Contact Person:*                         Rita Liu, PhD, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.                    

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Health Services Research.                    

*Date:*                         June 30, 2000.                    

*Time:*                         10 a.m. to 12 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hotel Washington, 515 15th Street NW, Washington, DC 20004.                    

*Contact Person*                         Susan L. Coyle, PhD, Chief, Clinical, Epidemiological and Applied Sciences Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.                     

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Treatment Research.                    

*Date:*                         June 30, 2000.                    

*Time:*                         1 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hotel Washington, 515 15th Street, NW, Washington, DC 20004.                    

*Contact Person:*                         Marina L. Volkov, PhD, Health Scientist Administrator, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1433.                     

*Name of Committee:*                         National Institute on Drug Abuse Initial Review Group, Training and Career Development Subcommittee.                    

*Date:*                         July 6-7, 2000.                    

*Time:*                         9 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814.                    

*Contact Person:*                         Mark Swieter, PhD, Health Scientist Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1389.                     

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, Program Projects.                    

*Date:*                         July 10, 2000.                    

*Time:*                         10 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda, MD 20814.                    

*Contact Person:*                         Khursheed Asghar, PhD, Chief, Basic Sciences Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 3158, Msc 9547, Bethesda, MD 29089-2954, (301) 443-2620.                     

*Name of Committee:*                         National Institute on Drug Abuse Special Emphasis Panel, The Next Generation of Drug Abuse Prevention Research.                    

*Date:*                         July 13, 2000.                    

*Time:*                        8:30 a.m. to 5 p.m.                     

*Agenda:*                        To review and evaluate grant applications.                     

*Place:*                        Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 20852.                     

*Contact Person:*                        William C. Grace, PhD, Deputy Director, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2755.                    

*Name of Committee:*                        National Institute on Drug Abuse Special Emphasis Panel, Microarray-Based Research On Drug Abuse.                     

*Date:*                        July 17-18, 2000.                     

*Time:*                        8:00 a.m. to 5:00 p.m.                     

*Agenda:*                        To review and evaluate grant applications.                     

*Place:*                        Marriott Hotel, 5151 Pooks Hill Road, Bethesda, MD 20814.                     

*Contact Person:*                        Rita Liu, PhD, Health Scientist Administrator, Office of Extramural Affairs. National Institute on Drug Abuse. National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.                    

*Name of Committee:*                        National Institute on Drug Abuse Special Emphasis Panel, Basic Behavioral, Cognitive, and Neurological Research: Applications to HIV/AIDS and Drug Abuse.                     

*Date:*                        July 20, 2000.                     

*Time:*                        8:30 a.m. to 5 p.m.                     

*Agenda:*                        To review and evaluate grant applications.                     

*Place:*                        Radisson Barcelo Hotel, 2121 P Street NW. Washington, DC 20037.                     

*Contact Person:*                        Marina L. Volkov, PhD, Health Scientist Administrator, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9597, (301) 435-1433.                    

*Name of Committee:*                    National Institute on Drug Abuse Special Emphasis Panel, HIV Therapy for Drug Users: Access, Adherence, Effectiveness.                 

*Date:*                    July 21, 2000.                 

*Time:*                    8:30 a.m. to 5 p.m.                 

*Agenda:*                    To review and evaluate grant applications.                 

*Place:*                    Radisson Barcelo Hotel 2121 P Street NW Washington, DC 20037.                 

*Contact Person:*                    Marina L. Volkov. PhD, Heath Scientist Administrator, Office of Extramural Program Review, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1433.                

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS).

Dated: May 12, 2000.

LaVerne Y. Stringfiled, 

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 00-12903  Filed 5-22-00; 8:45 am]

BILLING CODE 4140-01-M